NFE2L2 and cancer: Although the in vitro results of the use of Nrf2 inhibitors are promising, especially concerning sensitivity to chemotherapy of Nrf2-addicted cancers, the using systemic Nrf2 inhibitors may have pharmacological activity is unsatisfactory due to side effects caused by the essential roles of Nrf2 in cytoprotection.